leav target price
unchang retain outperform rate demonstr
resili on-going robust organ growth driven price
increas volum growth tough comp increas
ebitda margin target ahead f/person care peer highlight
competit advantag symris vertic integr busi model longer
term believ symris continu extract valu consolid
non-cor acquisit volum growth rate continu outperform
peer oper improv drive margin cash convers
move toward givaudan level chri counihan assum primari
coverag
price initi bear fruit believ symris continu price
ahead raw function consolid industri structur custom
sticki result abil continu suppli outag
basf citral plant strong demand non-cor area period
continu inflat initi continu
support margin without sacrif volum growth believ symris
expand gross margin follow improv
improv track improv margin
enabl target reach
valuat valu symris base averag dcf
sotp valuat method base pe ev/ebitda
averag peer consum stapl custom
wacc catalyst interim report octob risk raw materi
valuat metric
number share
price month
price rel chart measur perform
deutsch bors dax close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
symris global provid fragranc flavor activ
ingredi aroma chemic well sensori nutrit
solut perfum cosmet pharmaceut food beverag
pet food babi food industri
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
high singl digit growth ebitda multipl compar
base case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
digit growth ebitda multipl compar base
case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
price rel chart measur perform deutsch
bors dax close
spot exchang rate
lower forecast ebitda driven lower margin flavour nutrit
scent revis sale slightli weaker growth
margin came lower forecast expect slight
improv margin manag commit rais price off-set
raw materi price pressur continu believ divis improv margin
higher raw materi cost move year
flavour nutrit trim top-line reduc margin
primarili due short delay complet adf/idf product
new diana site impact nutrit well updat macro fx
forecast organ ebitda growth driven organ revenu
growth non-organ item follow
new invest symris ramp commerci sale cosmet
usa diana food usa menthol usa
adf/idf includ contribut adf/idf acquisit consolid
equat ebitda contribut
fx tailwind stronger usd
revers py tax credit
revers basf citral impact revers margin headwind
basf equat tailwind
ifr ebitda margin uplift
sale pinova industri
nutraceutix probi acquisit
new invest
basf citral impact
symris trade discount peer consensu month forward ev/ebitda
premium year histor averag discount
month forward price-to-earnings basi symris current trade premium peer
premium year histor averag
figur symris pe rel peer
figur symris ev/ebitda rel peer
compani mention price
